ALKS vs LYB · P/E 14, rev $1.56B vs P/E 21, rev $40.30B
Alkermes Plc (ALKS) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the ALKS and LYB stock pages for the full models.
Not investment advice.